0001944189-22-000004.txt : 20220902 0001944189-22-000004.hdr.sgml : 20220902 20220902152131 ACCESSION NUMBER: 0001944189-22-000004 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220902 DATE AS OF CHANGE: 20220902 EFFECTIVENESS DATE: 20220902 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Rose Therapeutics, Inc. CENTRAL INDEX KEY: 0001944189 IRS NUMBER: 882869520 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-457875 FILM NUMBER: 221224815 BUSINESS ADDRESS: STREET 1: 20 W. MAIN ST., 3RD FLOOR CITY: NORRISTOWN STATE: PA ZIP: 19401 BUSINESS PHONE: 917-453-2647 MAIL ADDRESS: STREET 1: 20 W. MAIN ST., 3RD FLOOR CITY: NORRISTOWN STATE: PA ZIP: 19401 D 1 primary_doc.xml X0708 D LIVE 0001944189 Rose Therapeutics, Inc. 20 WEST MAIN STREET, 3RD FLOOR NORRISTOWN PA PENNSYLVANIA 19401 917-453-2647 DELAWARE None None Corporation true 2022 Matthew Wotiz 20 WEST MAIN STREET, 3RD FLOOR Norristown PA PENNSYLVANIA 19401 Executive Officer Director Secretary Timothy Langloss 20 WEST MAIN STREET, 3RD FLOOR Norristown PA PENNSYLVANIA 19401 Executive Officer Director President Ira Sanders 5 Ryecliff Road Oarland NJ NEW JERSEY 09436 Director Biotechnology Decline to Disclose 06b false 2022-08-22 false true false 0 1000000 650000 350000 false 5 0 0 0 The Company expects to use the net proceeds from the Offering to fund operating expenses and for general working capital, fees and expenses. false Rose Therapeutics, Inc. /s/ Matthew Wotiz Matthew Wotiz Secretary 2022-09-02